On 4/19/2017, Shares of Conduent Incorporated’s (NYSE:CNDT) closed at $15.90 in last trading day. After noting the initial trading entry at $15.82, it reached to a day’s high of $16.06 and moved to a day’s low of $15.73. The recent daily volume was 1.24 million as contrast to it’s an average volume of 2.66 million.
The last close of the Conduent Incorporated’s stock reflects that it traded -0.74% from its 50-day moving average of $16.02. The stock traded above +3.96% to its 200-day MA of $15.29. Furthermore, it moved lower -8.83% from its 52-week high of $17.44 and +21.37% up from $13.10, which is 52-week low of the stock.
During the last month, Conduent Incorporated’s (CNDT) has changed -0.75% . The mean rating score for this stock is at 2.50. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 2.23% in recent month and observed Weekly Volatility of 1.77%.
April 17, 2017 Conduent Incorporated (CNDT) an industry leading business process services company, announced its Pharmacy Benefit Management (PBM) module, Conduent™ Flexible Rx System, has received federal certification in the state of Montana. This is the first instance of federal certification for Flexible Rx and the first time that certification has been granted to an individual Medicaid management module.
Flexible Rx is a comprehensive Pharmacy Benefit Management system, built on a web-based platform. It was designed to help states improve care while controlling costs. Its agile design can easily plug into modular frameworks or work in conjunction with existing legacy platforms. Flexible Rx enables states to quickly adapt to changes in federal regulations and updates to state policy.
The system provides:
Pharmacy Claims Processing: Flexible Rx streamlines the claims adjudication process through the electronic submission, transmission, and payment of prescription information for Medicaid, federal and commercial clients.
Prospective Drug Utilization Review (ProDUR): To promote positive outcomes, Flexible Rx evaluates claims against comprehensive ProDUR edits (including drug-drug interactions, therapeutic duplication, and incorrect dosage) which promotes prescribing compliance with evidence-based criteria. Our solution instantly alerts providers to potentially adverse interactions, ensuring members receive the safest and most cost-effective therapies.
Automated Prior Authorization processing: Combined with the Conduent™ SmartPA Pharmacy Application, Flexible Rx automates up to 90 percent of claims requiring prior authorization. This expedites medication dispensing and reduces the administrative burden on providers while reducing costs.
In 2016, the Centers for Medicare & Medicaid Services (CMS) developed a process for vendors to obtain modular certification. The certification was granted based on a complete virtual review of the systems capabilities – a first for CMS – and the latest federal checklists for modular solutions in the Medicaid Enterprise Certification Toolkit.
“CMS’ certification of Flexible Rx provides validation that a modular approach to these systems can work,” said David Hamilton, general manager, Government Healthcare Solutions, Conduent. “As a precedent, the certification will enable us to speed the process in other states.”
Campbell Soup Company (NYSE:CPB) finalized the last transaction at value of $57.28, with a daily change of +0.16% or +0.09 points. The company maintained volume of 1.08 million shares. In past trading day, the stock hit the maximum price of $57.41 and touched to minimum value of $56.92. It has a market cap of $ 17.43B.
As of last trade close, the stock is trading downside -15.63% from its one year high of $67.89 and moved +8.93% upward from $52.58, which is one year low of the stock.
The stock traded below -1.02% from its 50-day moving average of $57.87. Furthermore, the stock moved -1.45% to its 200-day MA of $ 58.12.
Campbell Soup Company’s (CPB) moved with shift of 1.13% in the past week. Over the last three months, the shares of the company have changed -7.47% and performed 8.00% over the last six months. The stock currently has Monthly Volatility of 1.25% and Weekly Volatility of 1.28%.